|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/38 | (2006.01) |
| (11) | Number of the document | 2694544 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12762959.0 |
| Date of filing the European patent application | 2012-03-30 | |
| (97) | Date of publication of the European application | 2014-02-12 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-23 |
| (46) | Date of publication of the claims translation | 2019-04-25 |
| (86) | Number | PCT/US2012/031538 |
| Date | 2012-03-30 |
| (87) | Number | WO 2012/135671 |
| Date | 2012-10-04 |
| (30) | Number | Date | Country code |
| 201161471101 P | 2011-04-01 | US |
| (72) |
WANG, Zhuozhi, US
MURPHY, John, US
MARQUARDT, Tobias, DE
MOOSMAYER, Dieter, DE
|
| (73) |
Bayer HealthCare LLC,
100 Bayer Boulevard, Whippany, NJ 07981-0915,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Monokloniniai antikūnai prieš audinių faktoriaus kelio slopiklį (TFPI) |
| MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI) |
| Payment date | Validity (years) | Amount | |
| 2019-03-21 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-03-30 |